Comments
Unichem Laboratories has informed the exchanges that it has received four observations from the United States Food and Drug Administration for its Goa formulations facility. There were no repeat observations and were mostly procedural in nature, the company said in a statement to the exchanges. The USFDA conducted inspection at Unichem’s Goa formulations facility between July 22 and July 31, 2019.
The inspection was a routine GMP surveillance and the company will provide the responses and corrective action plan within the next 15 working days to address the observations, it added. Shares of Unichem slipped 0.12 per cent at ₹167.35 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.